Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$592.1M+1.1%$693.2M+3.9%$653M+0.5%$651.6M+2.1%$585.4M-4.2%
$282.7M+1.2%$348M+6.9%$309.6M+5.4%$306.3M+8.1%$279.4M-1.9%
$309.4M+1.1%$345.2M+0.9%$343.4M-3.5%$345.3M-2.8%$306M-6.1%
52.3%0.0pp49.8%-1.4pp52.6%-2.2pp53%-2.6pp52.3%-1.1pp
$62.9M-14.4%$70.3M-11.7%$71.3M-21.6%$60.5M+2.7%$73.5M+10.7%
$212.4M+1.7%$221M+8.3%$206.8M+3.2%$207.7M+6.7%$208.8M-2.8%
$34.1M+43.9%$65.3M+1.2%$77.1M-24.0%$23.7M-46.9%
5.8%+1.7pp10%+0.1pp11.8%-4.1pp4%-3.3pp
$12.3M+2.5%$12.1M-0.8%$12.3M+1.7%$12.6M+2.4%$12M-2.4%
$24.2M-34.9%$28.6M+45.9%$8.3M-53.6%$16.2M-11.0%$37.2M+7.5%
-$689.8M-927%$929.2M+202%-$431.1M-150%$414M+115%$83.4M-83.0%
-$162.7M-939%$209.2M+208%-$89.2M-143%$96.2M+115%$19.4M-81.9%
-$19.55-954%$26.39+203%-$12.70-154%$11.67+115%$2.29-83.0%
$80.9M+21.1%$116.8M+7.5%$122.9M-14.2%$66.8M-23.4%
13.7%+2.3pp17.9%+1.2pp18.9%-3.6pp11.4%-2.9pp
$34.1M+43.9%$941.3M+1,515%$65.3M+1.2%$77.1M-24.0%$23.7M-46.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s revenue?
Bio-Rad Laboratories, Inc. (BIO.B) generated $2.6B in revenue over the trailing twelve months, up 1.9% year over year.
Is Bio-Rad Laboratories, Inc. profitable?
Bio-Rad Laboratories, Inc. reported $168.8M in net income over the trailing twelve months, a 6.5% net margin.
What are Bio-Rad Laboratories, Inc.'s profit margins?
Gross margin is 51.9% and operating margin is 8.8%, with a 6.5% net margin.
What is Bio-Rad Laboratories, Inc.'s earnings per share?
Bio-Rad Laboratories, Inc.'s diluted EPS over the trailing twelve months is $5.81.
Where does Bio-Rad Laboratories, Inc.'s income statement data come from?
Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.